Does Wellcare Cover Xarelto?
The verdict
Covered on most plans
Yes — Wellcare (Centene) covers Xarelto for atrial fibrillation, VTE, and cardiovascular risk reduction on its 2026 Part D plans and Medicaid managed-care plans. As a Part D sponsor, Wellcare is legally required to carry Xarelto at the 2026 IRA Maximum Fair Price of $197/month. The cost question is Tier 3 placement, common quantity limits, Wellcare's 5–6 tier structure, and the $2,100 annual out-of-pocket cap.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Wellcare using your member ID.
Key facts
Xarelto's 2026 IRA Maximum Fair Price is $197/30-day supply — a 62% reduction from the $517 list price, effective January 1, 2026.
CMS. Medicare Drug Price Negotiation Program — Negotiated Prices for Initial Price Applicability Year 2026.
The 2026 Medicare Part D out-of-pocket cap is $2,100 — after this point, Xarelto (and all Part D drugs) cost $0 for the remainder of the year.
CMS Final CY 2026 Part D Redesign Program Instructions.
Per Magnolia Market Access analysis, 66% of Part D beneficiaries are in plans that shifted IRA-negotiated drugs from a fixed copay to coinsurance in 2026 — meaning per-fill cost may be higher for some enrollees despite the lower list price.
Magnolia Market Access, 2025 Part D Coinsurance Shift Analysis.
Medicare vs. commercial coverage
Whether Wellcare covers Xarelto depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Covered on Wellcare's 2026 Part D plans (Value Script and Classic PDPs) as a Tier 3 preferred brand. Wellcare's tier structure has 5–6 tiers (Tier 1 preferred generic $0 at preferred pharmacy; Tier 3 preferred brand; Tier 6 for select chronic-condition drugs; $615 deductible; $2,100 out-of-pocket cap). As a Part D sponsor, Wellcare must carry Xarelto at the IRA 2026 Maximum Fair Price of $197/30-day supply (62% off the $517 list price), effective January 1, 2026. However, MFP is a payer-side ceiling — whether you pay a fixed copay or coinsurance determines your per-fill cost. The $2,100 OOP cap is the safety net. Quantity limits are common on Xarelto Part D plans; confirm your plan allows the full month's supply at your dose (10 mg, 15 mg, or 20 mg once daily; 15 mg twice daily during initiation). PA/step therapy uncommon on Medicare. Verify on your Wellcare plan drug list.
Commercial / Employer
Group & marketplace plans
Wellcare's commercial footprint is limited — it primarily operates Part D and Medicaid managed-care plans. Where Wellcare commercial coverage is offered, Xarelto is typically Tier 3 with quantity limits. Wellcare Managed Medicaid covers Xarelto across its state MCO plans; prior authorization may be required per state Medicaid PDL at $0–$10 cost-share. ACA/Individual coverage is also limited. Verify on your state-specific Wellcare plan drug list or contact Wellcare Member Services.
Your cost, three ways
What Xarelto actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
$500–$650/month retail (pharmacy-variable estimate; no generic Xarelto available as of 2026)
List price with no coverage — before any manufacturer savings card.
With coverage
Tier 3 cost-share after $615 deductible; capped at $2,100/year out-of-pocket — verify exact amount on your Wellcare plan
Typical monthly copay once prior authorization is approved.
Bridge program
J&J/Janssen savings card — $0 for commercially insured patients only; not available to Medicare or Medicaid beneficiaries. Contact Janssen CarePath at 1-855-XARELTO.
Reduced copay through the assistance program, where eligible.
IRA 2026 Maximum Fair Price for Xarelto is $197/30-day supply (effective 1/1/2026) — this is a payer-side ceiling, not an automatic copay. Whether you pay a fixed copay or coinsurance on a given Wellcare plan determines your per-fill amount. The $2,100 OOP cap limits annual exposure. All figures are estimates; verify cost-share with your specific Wellcare plan.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Xarelto on your Wellcare plan formulary
Log in to your Wellcare member account at wellcare.com or call Wellcare Member Services at the number on your ID card. Navigate to the drug list (formulary) and search for 'Xarelto' or 'rivaroxaban.' Confirm the tier, quantity limits, and your plan's cost-share for the 2026 plan year.
- 2
Ask your prescriber to verify the dose fits the plan's quantity limit
Wellcare Part D plans commonly apply quantity limits to Xarelto. Have your cardiologist or prescribing physician confirm the daily dose (e.g., 20 mg once daily for AFib) and days' supply against the plan's quantity limit. If a limit exception is needed, your doctor can request one through Wellcare's prior authorization process.
- 3
Fill at a preferred Wellcare network pharmacy
Using a Wellcare preferred pharmacy lowers your Tier 3 cost-share. Log in at wellcare.com to find preferred network pharmacies near you. Mail-order may also offer savings. Medicare beneficiaries cannot use the Janssen commercial savings card — verify applicable bridge programs with Wellcare directly.
Options if Wellcare won't cover Xarelto
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Eliquis (apixaban)
The other major DOAC for AFib and VTE. Also covered on Wellcare Part D as Tier 3 with a $231 IRA MFP in 2026 (vs. Xarelto's $197). No generic until approximately 2028. PA/step therapy is also uncommon for Eliquis on Medicare. Clinical choice between the two DOACs is a decision for your physician.
Warfarin (generic coumadin)
An older anticoagulant available as a low-cost generic. Typically Tier 1 on Wellcare Part D. Requires regular INR monitoring and dietary restrictions. Discussed with your physician if cost is a primary concern and you are stable on anticoagulation.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes — Wellcare covers Xarelto for its FDA-approved indications including atrial fibrillation, deep vein thrombosis, pulmonary embolism, and cardiovascular risk reduction in CAD/PAD, on its 2026 Part D plans and Medicaid MCOs. As a Part D sponsor Wellcare must carry the IRA negotiated price of $197/month. Typical placement is Tier 3 with quantity limits. Step therapy is uncommon. Verify your specific plan's drug list.
Wellcare's Xarelto cost-share depends on whether your plan uses a fixed copay or coinsurance at Tier 3. The IRA 2026 Maximum Fair Price of $197/month is the payer ceiling, not an automatic patient copay. After clearing the $615 Part D deductible, your per-fill cost depends on your plan's tier-3 structure. The $2,100 annual out-of-pocket cap is the hard ceiling for 2026. Confirm your exact cost on the Wellcare formulary or by calling Member Services.
Yes — Wellcare Managed Medicaid covers Xarelto across its state MCO plans, typically at $0–$10 cost-share. Prior authorization may be required depending on the state Medicaid Preferred Drug List. Step therapy is not typical for a DOAC anticoagulant. Because Wellcare's Medicaid plans vary by state, verify coverage and PA requirements on your state's Wellcare Medicaid drug list or call the Member Services number on your card.
Yes — Xarelto commonly carries quantity limits on Wellcare Part D plans, as is standard across most Medicare Part D formularies for DOACs. If your dose is 20 mg once daily for AFib, confirm the plan allows 30 tablets per fill. For 15 mg twice-daily acute VTE dosing, confirm 60 tablets. Your prescriber can request a quantity limit exception through Wellcare if needed. Quantity limit details are in the Wellcare plan drug list.
No — the J&J/Janssen Xarelto savings card ($0 cost for eligible commercially insured patients) is not available to Medicare or Medicaid beneficiaries, including Wellcare Part D and Wellcare Managed Medicaid members. The savings card applies only to commercial (employer/individual) insurance. Note that Janssen also retired its Xarelto donut-hole support program because Medicare eliminated the coverage gap. For Medicare members, the $2,100 annual OOP cap is the primary cost protection.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Wellcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.